. 2017 Nov 4;19(4):627–633. doi: 10.22074/cellj.2018.4577

Table 4.

Post-intervention metabolic profile of women with PCOS randomly allocated into the placebo and treatment (quercetin) groups


Characteristic	Quercetin n=42		Placebo n=40		Crude P value	Adjusted P value
Characteristic	Crude	Adjusted	Crude	Adjusted	Crude P value	Adjusted P value

Insulin (μIU/mL)	8.45 (0.34)	8.35 (0.15)	9.81 (0.41)	9.91 (0.15)	0.013^*	<0.001^*
FBS (mg/dl)	90.36 (1.03)	89.58 (0.23)	89.45 (0.98)	90.27 (0.23)	0.526	0.045^*
HOMA-IR	1.88 (0.09)	1.84 (0.03)	2.17 (0.11)	2.21 (0.04)	0.039	<0.001^*
All values are mean (SE). Crude Significances are based on independent t test and adjusted significances are based on ANCOVA with variables age, BMI, DBP, SHBG and considering baseline value of each variable as covariates. PCOS; Polycystic ovary syndrome, FBS; Fasting blood sugar, HOMA-IR; Homeostasis model assessment-insulin resistance, and ^*; Statistically significant (P<0.05).

All values are mean (SE). Crude Significances are based on independent t test and adjusted significances are based on ANCOVA with variables age, BMI, DBP, SHBG and considering baseline value of each variable as covariates. PCOS; Polycystic ovary syndrome, FBS; Fasting blood sugar, HOMA-IR; Homeostasis model assessment-insulin resistance, and *; Statistically zsignificant (P<0.05).